BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 27, 2022 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $2.95 billion.
GUIDANCE:
Boston Scientific sees Q2 2022 EPS of $0.41-$0.43. Boston Scientific sees Q2... More
